IMAXEMA 20mg / g+1mg / g cream medication leaflet

D07CC01 fusidic acid + betamethasone • Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, potent, combinations with antibiotics

The combination of fusidic acid and betamethasone is used to treat bacterial skin infections accompanied by severe inflammation. Fusidic acid is an antibiotic effective against gram-positive bacteria, particularly Staphylococcus aureus, while betamethasone is a potent corticosteroid that reduces inflammation, redness, and itching.

This combination is indicated for conditions such as infected dermatitis, infected eczema, or other inflammatory skin infections. Fusidic acid addresses the bacterial infection, while betamethasone alleviates inflammatory symptoms, promoting faster healing and greater patient comfort.

It is important to use this combination as directed by a doctor, as prolonged or excessive use of corticosteroids can lead to skin thinning or other side effects. The treatment should be limited to affected areas and should not be applied to open wounds or healthy skin.

General data about IMAXEMA 20mg / g+1mg / g

Substance: fusidic acid + betamethasone

Date of last drug list: 01-02-2026

Commercial code: W71614001

Concentration: 20mg / g+1mg / g

Pharmaceutical form: cream

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: KYMOS, S.L. - SPANIA

Holder: LABORATOIRES BAILLEUL S.A. - LUXEMBURG

Number: 16371/2025/01

Shelf life: 3 years-after packing for marketing;after the first opening of the tube-6 months

Concentrations available for fusidic acid + betamethasone

20mg/1mg/g, 20mg/g+1mg/g